Enable living therapies

Turn cells into personalized therapies, tissues, and organs


Beyond 'one therapy fits all'

We believe patients will be able to say goodbye to

the 'one-treatment-fits-all' approach of today,

and receive fully personalized care

Antleron envisions living therapies to become a

sustainable reality through personalized manufacturing 4.0

We are on a mission to fast track regenerative medicine innovations and personalized advanced therapies from lab to patient

We co-create end-to-end solutions to

accelerate the engineering of advanced therapies,

change health care and result in a better life for all

Cell by Design 


Master your ATMP development process with Cell by Design®

Schermafbeelding 2019-10-07 om 23.20_edi

In the media

"Antleron's living therapy factory

integrates a cross-over

of (bio)technologies"

- Jan Schrooten

Antleron Co-Founder & CEO

Project in the picture

Persomed partners will jointly develop

an innovative colon cancer vaccine

Background (2).png

Ecosystem projects


Fellow Friday

Event report

Advanced Therapies Congress in London

Pre-conference workshop by Antleron

CEO Jan Schrooten: 'Turn cells into therapies

by end-to-end innovative strategies


Engineering Life

qbd approach.jpg

Quality by Design methodology

Enabling sustainable ATMP development

and scalable manufacturing